NCT06127511 Peanut Consumption on Cognitive, Weight, and Inflammation
| NCT ID | NCT06127511 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Barcelona |
| Condition | Cognitive Performance |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-01-29 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-01-29 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A multi-school, two-arm parallel cluster-randomized controlled trial will be conducted in 200 healthy young adolescents from Barcelona (Spain) to evaluate the effect of peanut consumption on cognitive performance, weight management and inflammation. Schools willing to participate will be randomly assigned to either the intervention or the control group. After the recruitment, the participants will follow a peanut-free diet for two weeks. Both arms will receive a multidimensional educational intervention designed by the Gasol Foundation to promote healthy dietary habits based on Mediterranean diet recommendations, along with exercise performance, healthy sleeping habits and emotional knowledge. Half of the participants (intervention group) will consume 25 g of whole skin roasted peanuts as a daily snack to be incorporated into their diet for six months.
Eligibility Criteria
Inclusion Criteria: Eligible participants will be young adolescents, boys and girls, aged between 10 and 12 years who attend regular primary schools in Barcelona. The schools will assist with the participant recruitment through the classes and after that, a total of one-hundred students will be randomly included in each group. In all cases, participation will be voluntary and informed consent will be obtained prior to the study. Exclusion Criteria: The exclusion criteria will be history of allergy or intolerance to peanuts, any medical conditions or dietary restrictions that would affect peanut consumption, being able to understand Spanish or Catalan, and use of antibiotics in the month prior to the study.
Frequently Asked Questions
Who can join the NCT06127511 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 12 Years, studying Cognitive Performance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06127511 currently recruiting?
Yes, NCT06127511 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Barcelona to inquire about joining.
Where is the NCT06127511 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT06127511 clinical trial?
NCT06127511 is sponsored by University of Barcelona. The trial plans to enroll 200 participants.